“The Poonawalla Group has been a visionary in many fields and green energy is no exception. This is the second order by them and it brings to the forefront their commitment to utilise wind energy across all their operations. It also highlights our value proposition and ability to deliver across all industry verticals. We acknowledge with gratitude the confidence reposed by Serum in Suzlon and look forward to strengthening our relationship with the group,” said Tulsi R Tanti, Chairman and Managing Director of Suzlon Energy Limited.
Serum Institute of India Limited (wholly owned by the Poonawalla Group) has made great strides from its humble beginnings in 1966; today, they are established as the world's largest producer of Measles and DTP group of vaccines. The project is Poonawalla Group’s second order with Suzlon and is set to be commissioned by March 2011.
“In all our initiatives we have partnered with the best and this is no exception. We believe that Suzlon with its rich experience will help Serum in its goal to contribute to the conservation of the environment at large. We have complete faith in Suzlon’s reliable technology, efficient execution and close collaborative approach and we look forward to building a successful project,” commented Serum Institute Chairman,Dr. Cyrus S. Poonawalla.
Suzlon, the leader in the Indian wind energy stage, has maintained market leadership by capturing ~50% market share for 12 consecutive years. Suzlon offers the concept-to-commissioning business model to wind energy investors in India – providing a comprehensive suite of services from turbine supply, to EPC, lifetime operations and maintenance and other value added services covering the entire value chain. The success of the model is seen in Suzlon’s rapid growth in India – with over 40 sites across eight states, and an installed base more than 5,000 MW and a customer portfolio that captures the leaders of the Indian Industry.
For additional information:
____________________________________________________________________
